EUVIMEDEUVIMED entdecken
Crossref

Use of crushed tranexamic acid tablets in water for paediatric patients with bleeding disorders

Ahmad Al-Huniti iD, Linda Marshall, Dawn Rusk, Rajiv K Pruthi iD, Vilmarie Rodriguez, Asmaa Ferdjallah, Alexis Kuhn

Haemophilia · 2024

DOI: 10.1111/hae.14996 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Haemophilia, 2024. Verfasst von Ahmad Al-Huniti und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Hematology/Oncology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Tranexamic Acid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ε‐Aminocaproic acid oral solution (EACA OS) is the only commercially available antifibrinolytic for patients who cannot swallow tablets. Insurance denials and high costs remain barriers to its use.

Objectives

To determine the safety and efficacy of crushed tranexamic acid tablets in water (cTXAw) for children with bleeding disorders.

Methods

We retrospectively reviewed records of children ( .1). No patients had adverse effects. Eight of 19 patients (42%) who were initially prescribed EACA OS did not receive it because of cost or insurance denial. The estimated average wholesale price of one treatment was $94 for cTXAw and $905 for EACA OS.

Conclusions

CTXAw appears to be an effective, safe, and low‐cost alternative option to EACA OS for young children with bleeding disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tranexamic AcidHumansMaleChild, PreschoolFemaleChildRetrospective StudiesTabletsInfantAntifibrinolytic AgentsWaterHemorrhageBlood Coagulation Disorders

Stichwörter der Autor:innen

antifibrinolytic agentsblood coagulation disordersblood platelet disordershaemophilia Ahaemophilia Bpaediatricsthrombocytopeniatranexamic acidvon Willebrand diseases

Substanzen

Tranexamic AcidTabletsAntifibrinolytic AgentsWater

Autor:innen und Institutionen

  • Division of Pediatric Hematology/Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Pharmacy, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Nursing, Mayo Clinic, Rochester, Minnesota, USA.
  • Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Division of Hematology/Oncology and BMT, Nationwide Children's Hospital, Columbus, Ohio, USA.

ORCID-Profile: Ahmad Al-Huniti, Rajiv K Pruthi

Zitieren

APA

Al-Huniti, A., Marshall, L., Rusk, D., Pruthi, R. K., Rodriguez, V., Ferdjallah, A., & Kuhn, A. (2024). Use of crushed tranexamic acid tablets in water for paediatric patients with bleeding disorders. Haemophilia. https://doi.org/10.1111/hae.14996

Vancouver

Al-Huniti A, Marshall L, Rusk D, Pruthi RK, Rodriguez V, Ferdjallah A, et al. Use of crushed tranexamic acid tablets in water for paediatric patients with bleeding disorders. Haemophilia. 2024. doi:10.1111/hae.14996

BibTeX
@article{AlHuniti2024,
  author = {Al-Huniti, Ahmad and Marshall, Linda and Rusk, Dawn and Pruthi, Rajiv K and Rodriguez, Vilmarie and Ferdjallah, Asmaa and Kuhn, Alexis},
  title = {Use of crushed tranexamic acid tablets in water for paediatric patients with bleeding disorders},
  journal = {Haemophilia},
  year = {2024},
  doi = {10.1111/hae.14996}
}
Kostenlos starten →